Renovorx Stock Last Dividend Paid
RNXT Stock | USD 1.26 0.10 7.35% |
RenovoRx fundamentals help investors to digest information that contributes to RenovoRx's financial success or failures. It also enables traders to predict the movement of RenovoRx Stock. The fundamental analysis module provides a way to measure RenovoRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RenovoRx stock.
RenovoRx | Last Dividend Paid |
RenovoRx Company Last Dividend Paid Analysis
RenovoRx's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
RenovoRx Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for RenovoRx is extremely important. It helps to project a fair market value of RenovoRx Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since RenovoRx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RenovoRx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RenovoRx's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, RenovoRx has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
RenovoRx Fundamentals
Return On Equity | -1.55 | ||||
Return On Asset | -0.7 | ||||
Current Valuation | 23.08 M | ||||
Shares Outstanding | 24 M | ||||
Shares Owned By Insiders | 1.90 % | ||||
Shares Owned By Institutions | 8.18 % | ||||
Number Of Shares Shorted | 86.95 K | ||||
Price To Book | 4.62 X | ||||
EBITDA | (11.4 M) | ||||
Net Income | (10.23 M) | ||||
Cash And Equivalents | 10.77 M | ||||
Cash Per Share | 1.19 X | ||||
Total Debt | 4.47 M | ||||
Current Ratio | 10.01 X | ||||
Book Value Per Share | (0.28) X | ||||
Cash Flow From Operations | (10.26 M) | ||||
Short Ratio | 3.43 X | ||||
Earnings Per Share | (0.58) X | ||||
Target Price | 5.25 | ||||
Beta | 0.99 | ||||
Market Capitalization | 32.64 M | ||||
Total Asset | 1.47 M | ||||
Retained Earnings | (41.41 M) | ||||
Working Capital | 291 K | ||||
Net Asset | 1.47 M |
About RenovoRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RenovoRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RenovoRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RenovoRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.